ScioScientific LLC

10/10/2025

Jim O’Neill, serving as acting CDC director, has called for the combined MMR vaccine to be “broken up” into three separate shots, despite lack of evidence supporting such a move. Experts warn this could undermine vaccine confidence and complicate immunization schedules.

https://www.statnews.com/2025/10/06/trump-official-jim-oneill-break-up-mmr-vaccine/

10/09/2025

Autism researcher Robert Hendren has lowered expectations for leucovorin, saying he hasn’t seen “remarkable” results. While it may help a subset of patients, it’s not a cure-all, underscoring how complex autism treatments remain. Read more on this.

STAT spoke with Robert Hendren, a retired UCSF researcher who conducted a small study of leucovorin in children with autism in 2020.

10/08/2025

The “hospital-at-home” program, which lets patients receive inpatient-level care at home under Medicare waivers, is winding down as those waivers expire, potentially forcing patients back into hospitals during a time of strained capacity. Here's more on this.

Hundreds of hospital at home programs are shutting down as Medicare’s pandemic-era waiver nears expiration, straining ERs and patient care nationwide.

10/07/2025

At El Salvador’s Hospital Bloom, pediatric partnerships with Careways Collaborative have helped drop newborn mortality rates—from around 22% to under 10%, through simple, scalable improvements in ICU and airway care. A single child’s survival might seem small, but the ripple effects in local care quality and medical training are enormous. Here's more on this.

Is it ethical to perform a high-risk surgery to save one infant in a country where health care resources are limited?

10/06/2025

A striking new study finds that over 99% of people who experience a first heart attack, stroke, or heart failure already had at least one risk factor—like high blood pressure, cholesterol, blood sugar, or smoking. Prevention matters more than ever. Here's more on this.

Study finds 99% of all heart attacks, heart failure, or strokes occur in people with "suboptimal" blood pressure, cholesterol, blood glucose, or smoking history.

10/05/2025

Mifepristone, first approved by the FDA in 2000 celebrates 25 years of use amid renewed political and legal challenges. Despite decades of scientific data supporting its safety and efficacy, the abortion pill remains a flashpoint in U.S. reproductive healthcare. Here's more on this.

Mifepristone has played a disruptive and transformational role in today’s abortion access landscape, writes Plan C’s Elisa Wells.

10/04/2025

Trump is threatening to impose 100% tariffs on pharmaceutical imports—unless drugmakers build manufacturing operations in the U.S. It’s a high-stakes demand that could reshape global supply chains and drug access. Here's more on this.

The president threatened tariffs on pharmaceuticals, days before a deadline he set for drug companies to lower their prices.

10/03/2025

The FDA is moving to approve leucovorin (Wellcovorin)—a drug once phased out—to treat symptoms linked to autism, particularly in cases tied to cerebral folate deficiency. It’s a bold shift, but one that’s drawing both hope and cautious scrutiny from scientists. Read more on this.

The Trump administration is touting leucovorin as a treatment for autism.

10/03/2025

President Trump’s claims linking prenatal Tylenol use to autism are drawing pushback—European regulators say the evidence doesn’t support such conclusions. The debate highlights how cautious we need to be when translating early research into public health guidance. Read more on this.

Regulators in Europe have issued new statements backing the safety of Tylenol use in pregnancy, effectively repudiating claims from the Trump administration.

10/01/2025

Evidence-based medicine should guide policy—not be distorted to restrict care. Gordon Guyatt stresses the importance of keeping science and compassion at the center of gender-affirming care. Read more on this.

Gordon Guyatt, a co-author of systematic reviews of gender-affirming care, calls use of the findings to justify banning care "egregious."

09/30/2025

President Trump’s administration is proposing new guidance linking prenatal acetaminophen (Tylenol) use to autism risk and pushing for use of leucovorin as a treatment for symptoms associated with autism. Experts caution the evidence is limited and hopeful, but stress calls for more rigorous studies before making sweeping changes. Here's more on this.

https://www.statnews.com/2025/09/22/trump-autism-action-plan-tylenol-link-leucovorin-treatment/

09/29/2025

Some hospitals may be avoiding detection of infections—or discouraging staff from reporting them—because of fear of fines. That’s being called “health care’s dirty little secret.” If we want safer care, transparency and accountability must be non-negotiable. Read more on this.

A STAT Investigation: To avoid fines for reporting excessive hospital-acquired infections, some facilities are discouraging testing.